NASDAQ:CRBP
Corbus Pharmaceuticals Holdings, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.corbuspharma.comipo date
Oct 27, 2014
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibod...Show More
Earnings
Earnings Release in 10 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus